BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21702220)

  • 21. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML; Weber A; Béhé M; Göke R; Joba W; Schmidt H; Bert T; Simon B; Arnold R; Heufelder AE; Behr TM
    Cancer Res; 2003 Mar; 63(6):1333-8. PubMed ID: 12649195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the sodium/iodide symporter by retinoids--a review.
    Schmutzler C
    Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells.
    Kogai T; Kanamoto Y; Li AI; Che LH; Ohashi E; Taki K; Chandraratna RA; Saito T; Brent GA
    Endocrinology; 2005 Jul; 146(7):3059-69. PubMed ID: 15817668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mammary gland iodide transporter is expressed during lactation and in breast cancer.
    Tazebay UH; Wapnir IL; Levy O; Dohan O; Zuckier LS; Zhao QH; Deng HF; Amenta PS; Fineberg S; Pestell RG; Carrasco N
    Nat Med; 2000 Aug; 6(8):871-8. PubMed ID: 10932223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
    Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
    Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
    Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
    Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel loss-of-function deletion in sodium/iodide symporter gene in follicular thyroid adenoma.
    Liang JA; Chen CP; Huang SJ; Ho TY; Hsiang CY; Ding HJ; Wu SL
    Cancer Lett; 2005 Dec; 230(1):65-71. PubMed ID: 16253762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats.
    Faivre J; Clerc J; Gérolami R; Hervé J; Longuet M; Liu B; Roux J; Moal F; Perricaudet M; Bréchot C
    Cancer Res; 2004 Nov; 64(21):8045-51. PubMed ID: 15520214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E; Hagan C; Qi J; Seregina T; Link C
    Anticancer Res; 2003; 23(3B):2397-404. PubMed ID: 12894520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
    J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
    Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
    Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell line.
    Arturi F; Ferretti E; Presta I; Mattei T; Scipioni A; Scarpelli D; Bruno R; Lacroix L; Tosi E; Gulino A; Russo D; Filetti S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2321-6. PubMed ID: 15623812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients.
    Yildirim-Poyraz N; Yazgan A; Ozdemir E; Gozalan A; Keskin M; Ersoy R; Turkolmez S; Cakir B
    Ann Nucl Med; 2014 Aug; 28(7):623-31. PubMed ID: 24823701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
    Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
    Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
    Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
    Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.